Drug Type Small molecule drug |
Synonyms Glustat, Voglibose (JP17/USAN/INN), Voglistat + [8] |
Action inhibitors |
Mechanism GANC inhibitors(glucosidase alpha, neutral C inhibitors), MGAM inhibitors(Maltase-glucoamylase inhibitors), α-glucosidase inhibitors(Acidic alpha-glucosidase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization |
Drug Highest PhaseApproved |
First Approval Date Japan (01 Jul 1994), |
Regulation- |
Molecular FormulaC10H21NO7 |
InChIKeyFZNCGRZWXLXZSZ-CIQUZCHMSA-N |
CAS Registry83480-29-9 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Diabetes Mellitus | China | 01 Jan 2001 | |
Diabetes Mellitus | China | 01 Jan 2001 | |
Diabetes Mellitus, Type 2 | Japan | 01 Jul 1994 | |
Diabetes Mellitus, Type 2 | Japan | 01 Jul 1994 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Glucose Intolerance | Clinical | China | 01 Jul 2008 |
Phase 4 | 494 | enmdnghvkg(iebxaaygiq) = ghaczzeeqt lpeudexszb (zhzlehfaeg, 0.0742) View more | - | 04 Feb 2019 | |||
enmdnghvkg(iebxaaygiq) = msdfiagyui lpeudexszb (zhzlehfaeg, 0.0764) View more | |||||||
Phase 4 | 197 | rfdcbsbqgp = mpikhnzpfu mzrfahunej (dppnryvzld, wwhomjrtyt - rwkuyfeqjs) View more | - | 09 Apr 2015 | |||
Phase 1 | - | 22 | Metformin | nrhcqjexsm(hhaolaupqe): geometric mean ratio = 0.99 (90% CI, 0.92 - 1.06), P-Value = > 0.05 View more | - | 01 Nov 2014 | |
Metformin + Voglibose | |||||||
Phase 3 | 133 | Sitagliptin 50 mg/day | nyfvvgjwhl(soxiwvqnzl) = ptubuzkbtd seyyfsakxz (qnuhacvmzc ) View more | - | 27 Nov 2013 | ||
Phase 3 | 319 | Sitagliptin 50 mg once daily | lfnabkutxr(nttkfvykst) = pyseywzqmy kuqersqhcp (otduzaeytj, -0.8 to -0.6) View more | Positive | 01 Jul 2010 | ||
Voglibose 0.2 mg thrice daily | lfnabkutxr(nttkfvykst) = qvhagtvfxu kuqersqhcp (otduzaeytj, -0.4 to -0.2) View more |